ArticlePsychopharmacology2026
Modulatory effects of α7-nicotinic cholinergic receptors on perceptual sensitivity in a visual signal detection task.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleCholinergic signalling is critical for attentional control and signal detection, yet the contribution of specific acetylcholine receptor (AChR) subtypes remains poorly understood. Although the α7 nicotinic AChR (nAChR) holds promise as a target for cognition-enhancing therapy, clinical findings to date have been inconsistent.
objectiveTo investigate the effects of putative cognitive enhancing drugs, including those targeting cholinergic transmission and α7 nAChRs on a visual signal detection task (SDT).
methodsMale and female Sprague Dawley rats were trained on an SDT. Cholinergic transmission was probed systemically with nicotinic and muscarinic receptor antagonists (mecamylamine and scopolamine), a cholinesterase inhibitor (galantamine), an M4-AChR positive allosteric modulator (PAM; VU0467154), an α7 nAChR antagonist (MLA), an α7 nAChR PAM (CCMI), and an α7 nAChR partial agonist (SSR-180,711). Catecholaminergic transmission was probed using the catechol-O-methyltransferase (COMT) inhibitor tolcapone. A novel, trial-level signal detection theory-based generalised linear mixed-effects model (SDT-GLMM) was used to index response bias and perceptual sensitivity (d'), the latter reflecting subjects' ability to discriminate signal from noise.
resultsHigh dose mecamylamine impaired d' and hit rate and slowed responding. Galantamine significantly improved d' at moderate doses but not when a distractor was present. MLA produced dose-dependent improvements in d' that were preserved under distraction. In contrast, positive allosteric modulation and activation of α7 nAChRs impaired task performance. Scopolamine produced marked behavioural slowing, whereas VU0467154 and tolcapone did not reliably affect d'.
conclusionsThese findings demonstrate that α7 nAChR modulation bidirectionally and dose-dependently regulates perceptual sensitivity, irrespective of attentional distraction. These findings have implications for targeted cognitive enhancement in disorders of attention.
Indexed as
Identifiers
42771164What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.